Sociodemographic disparities in GLP-1RA and SGLT2i use among US adults with type 2 diabetes: NHANES 2005-March 2020.

Benjamin G MittmanPhuc LeJulia Y PayneGina AyersMichael B Rothberg

Published in: Current medical research and opinion (2024)

The use of GLP-1RA/SGLT2i drugs increased over time but remained low in March 2020. Higher education and income, but not race/ethnicity, were associated with GLP-1RA/SGLT2i use.

Keyphrases

rheumatoid arthritis
disease activity
ankylosing spondylitis
healthcare
interstitial lung disease
systemic lupus erythematosus
quality improvement
drug induced